About InDevR-Based in Boulder, CO, InDevR is a biotechnology company poised to significantly impact vaccine process optimization and manufacturing with powerful new protein characterization tools. With a strong history of non-dilutive funding raises, including a $14.7M BARDA contract to develop a high information content influenza diagnostic and recent investment from the Bill & Melinda Gates Foundation to advance measles and rubella vaccine characterization, InDevR has launched several successful life science tool-based product lines including VaxArray and Cypher One.
| Website | http://www.indevr.com |
| Revenue | $5.6 million |
| Funding | $10.2 million |
| Employees | View employees |
| Address | 2100 Central Ave, Ste 106, Boulder, Colorado 80301, US |
| Phone | +1 303-402-9100 |
| Fax | (303) 402-9300 |
| Industry | Biotechnology, Pharmaceuticals, Healthcare |
| Competitors | Siemens, Roche, Medtronic, Thermo Fisher Scientific, Abbott, BD, Hologic, Inc., Cepheid, bioMérieux, PerkinElmer, Inc. +41 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325414 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular InDevR employee's phone or email?
InDevR Questions
The InDevR annual revenue was $5.6 million in 2026.
InDevR is based in Boulder, Colorado.
The NAICS codes for InDevR are [325414, 32, 3254, 32541, 325].
The SIC codes for InDevR are [283, 28].
